Inhibitory effect of nicorandil on the contraction of isolated human urinary bladder detrusor muscle

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 30, Issue 5, 2008, Pages 363-366

  Faruqui, Atiya R ^a   Mathai, John ^a   George, Jacob ^a   Peedicayil, Jacob ^a   Ernest, Kalpana ^a   Neelakantan, Nithya ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Contraction; Detrusor muscle; Nicorandil

Indexed keywords

GLIBENCLAMIDE; NICORANDIL; POTASSIUM CHLORIDE;

ARTICLE; BLADDER SURGERY; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; MALE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NICORANDIL; POTASSIUM CHLORIDE; URINARY BLADDER; VASODILATOR AGENTS;

EID: 52649102370     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2008.30.5.1186078     Document Type: Article

References (23)

1. Wein, A.J. Pharmacologic options for the overactive bladder. Urology 1998, 51(2A, Suppl.): 43-7.
2. Elliott, R.A., Norman, R.I., Parker, S.G, Whitaker, R.P., Castledon, C.M. Effect of treatment with calcium antagonists in vitro and in vivo on the contractile response of isolated rat and human detrusor muscle. Clin Sci 1996, 91(4): 467-74.
3. Lose, G., Jorgensen, L., Thunedborg, P. Doxepin in the treatment of female detrusor overactivity: A randomized double-blind crossover study. J Urol 1989, 142(4): 1024-6.
4. Fraser, M.O., Lavelle, J.P., Sacks, M.S., Chancellor, M.B. The future of bladder control - Intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol 2002, 4(1): 1-11.
5. Ropper, A.H., Brown, R.H. Adams and Victor's Principles of Neurology, 8th Ed. McGraw-Hill, New York, 2005, 467-70.
6. Rajkumar, G.N., Small, D.R., Mustafa, A.W., Conn, G. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle inpatients with refractory idiopathic detrusor overactivity. BJU Int 2005, 96(6): 848-52.
7. Safarinejad, M.R., Hosseini, S.Y. Safety and clinical efficacy of tramadol in the treatment of idiopathic detrusor overactivity: A double-blind, placebo-controlled study. Br J Clin Pharmacol 2006, 61(4): 456-63.
8. Markham, A., Plosker, G.L., Goa, K.L. Nicorandil: An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs 2000, 60(4): 955-74.
9. Parimala, K., Peedicayil, J., Peedicayil, A., Nelson, N., Ernest, K. The effect ofa nicorandil congener on isolated human myometrium. Eur J Obstet Gynecol Reprod Biol 2006, 126(2): 176-9.
10. Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W. et al. Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 1995, 268(5209): 423-6.
11. Barcenilla, A., Alamo, C., Carvajal, A., Garcia-Pozo, J., Velasco, A. Effect of nicorandil upon guinea-pig and rat isolated organ preparations in vitro. Arzneimittelforschung 2000, 50(4): 341-4.
12. Weiss, R., Mevissen, M., Hauser, D.S. et al. Inhibition of human and pig ureter motility in vitro and in vivo by the K+ channel openers PKF 217-744b and nicorandil. J Pharmacol Exp Ther 2002, 302(2): 651-8.
13. Hsieh, G.C., Kolasa, T., Sullivan, J.P., Brioni, J.D. Dual mechanism of action of nicorandil on rabbit corpus cavernosal smooth muscle tone. Int J Impot Res 2001, 13(4): 240-6.
14. ATP channel activation. Jpn J Pharmacol 2000, 84(3): 316-24.
15. Zhou, Q., Satake, N., Shihata, S. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery. Eur J Pharmacol 1995, 273(1-2): 153-9.
16. + current. J Physiol 2003, 549(Pt. 1): 65-74.
17. Brading, A.F. Spontaneous activity of lower urinary tract smooth muscles: Correlation between ion channels and tissue function. J Physiol 2006, 570(Pt. 1): 13-22.
18. Christ G.J., Hodges, S. Molecular mechanisms of detrusor and corporal myocyte contraction: Identifying targets for pharmacotherapy of bladder and erectile dysfunction. Br J Pharmacol 2006, 147(S2): S41-55.
19. Chu, F.M., Dmochowski, R. Pathophysiology of overactive bladder. Am J Med 2006, 119(3A): 3S-8S.
20. Nevéus, T. The evaluation and treatment of therapy-resistant enuresis: A review. Ups J Med Sci 2006, 111(1): 61-72.
21. Staskin, D.R., MacDiarmid, S.A. Using anticholinergics to treat overactive bladder: The issue of treatment tolerability. Am J Med 2006, 119(3A): 9S-15S.
22. Fovaeus, M., Andersson, K.E., Hedlund, H. The action of pinacidil in the isolated human bladder. J Urol 1989, 141(3): 637-40.
23. de Moura, R.S., de Mello, R.F., D'Aguinaga, S. Inhibitory effect of cromokalim in human detrusor muscle is mediated by glibenclamide-sensitive potassium channels. J Urol 1993, 149(5): 1174-7.